Back to Search
MICHAEL KEATING, M.D.
M.D.
Medical Oncology Physician
NPI: 1801980560Individual
Specialties, Licenses & Credentials
Medical Oncology PhysicianPrimary
Internal Medicine — Medical Oncology
Code: 207RX0202X
E4447(TX)
Research & Publications (20)
Customized oligonucleotide array-based comparative genomic hybridization as a clinical assay for genomic profiling of chronic lymphocytic leukemia.
PMID 19074592·J Mol Diagn·2009
8-other
Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia.
PMID 15767648·J Clin Oncol·2005
3-trial
Evolution of treatment strategies in chronic lymphocytic leukemia. Part 2 of a 3-Part series: Advances in the treatment of hematologic malignancies.
PMID 16201050·Clin Adv Hematol Oncol·2005
8-other
Management guidelines for use of alemtuzumab in B-cell chronic lymphocytic leukemia.
PMID 15072613·Clin Lymphoma·2004
8-other
Biology and treatment of chronic lymphocytic leukemia.
PMID 14633781·Hematology Am Soc Hematol Educ Program·2003
6-review
Results of first salvage therapy for patients refractory to a fludarabine regimen in chronic lymphocytic leukemia.
PMID 12685828·Leuk Lymphoma·2002
8-other
Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study.
PMID 11986207·Blood·2002
3-trial
Management of chronic lymphocytic leukemia: a changing field.
PMID 12823777·Rev Clin Exp Hematol·2002
6-review
Emerging information on the use of rituximab in chronic lymphocytic leukemia.
PMID 11842391·Semin Oncol·2002
6-review
Campath-1H treatment of T-cell prolymphocytic leukemia in patients for whom at least one prior chemotherapy regimen has failed.
PMID 11773171·J Clin Oncol·2002
4-observational
Progress in CLL, chemotherapy, antibodies and transplantation.
PMID 11769960·Biomed Pharmacother·2001
8-other
Chronic lymphocytic leukemia . Clinical oral poster session.
PMID 11036949·Hematol Cell Ther·2000
6-review
Prediction of prognosis following fludarabine used as secondary therapy for chronic lymphocytic leukemia.
PMID 10721771·Leuk Lymphoma·2000
8-other
Fludarabine, cyclophosphamide, mitoxantrone plus rituximab (FCM-R) in frontline CLL <70 Years.
PMID 19646755·Leuk Res·2010
3-trial
B-cell antigen receptor signaling enhances chronic lymphocytic leukemia cell migration and survival: specific targeting with a novel spleen tyrosine kinase inhibitor, R406.
PMID 19491390·Blood·2009
7-preclinical
Healthcare-associated hepatitis C virus transmission among patients in an abdominal organ transplant center.
PMID 19497073·Transpl Infect Dis·2009
8-other
A phase 2 study of yttrium-90 ibritumomab tiuxetan (Zevalin) in patients with chronic lymphocytic leukemia.
PMID 19637351·Cancer·2009
3-trial
Proteasome enzymatic activities in plasma as risk stratification of patients with acute myeloid leukemia and advanced-stage myelodysplastic syndrome.
PMID 19458051·Clin Cancer Res·2009
8-other
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
- Address
- 1515 HOLCOMBE BLVD, 77030-4009
HOUSTON, TX 77030 - Phone
- (713) 792-6161
Quick Facts
- NPI
- 1801980560
- Entity Type
- Individual
- Gender
- Male
- Medicare
- Not confirmed
- Specialties
- 1
- Locations
- 1
- Publications
- 20
Are you this provider?
Claim Your Profile